Cargando…
COVID‐19: lambda interferon against viral load and hyperinflammation
Coronavirus disease 2019 (COVID‐19), triggered by the betacoronavirus SARS‐CoV‐2, has become one of the worst pandemics of our time that has already caused more than 250,000 deaths (JHU data‐05/06/2020, https://coronavirus.jhu.edu/). Effective therapeutic approaches are urgently needed to reduce the...
Autores principales: | Andreakos, Evangelos, Tsiodras, Sotirios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267110/ https://www.ncbi.nlm.nih.gov/pubmed/32333818 http://dx.doi.org/10.15252/emmm.202012465 |
Ejemplares similares
-
Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control
por: Andreakos, Evangelos, et al.
Publicado: (2019) -
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling
por: Hasan, Djo, et al.
Publicado: (2021) -
Lockdowns and the COVID-19 pandemic: What is the endgame?
por: Lytras, Theodore, et al.
Publicado: (2020) -
COVID-19 and emerging viral infections: The case for interferon lambda
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2020) -
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19
por: Meletiadis, Joseph, et al.
Publicado: (2020)